340
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups

, , , &
Pages 4147-4158 | Published online: 31 Jul 2012

References

  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin201161699021296855
  • Clarke-PearsonDLClinical practice. Screening for ovarian cancerN Engl J Med200936117017719587342
  • LiuJROpipariAWTanLDysfunctional apoptosome activation in ovarian cancer: implications for chemoresistanceCancer Res20026292493111830553
  • MezzanzanicaDCanevariSCeccoLDBagnoliMmiRNA control of apoptotic programs: focus on ovarian cancerExpert Rev Mol Diagn20111127728621463237
  • CastinoRDémozMIsidoroCDestination ‘lysosome’: a target organelle for tumour cell killing?J Mol Recognit20031633734814523947
  • DuvvuriMKriseJPIntracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic reviewFront Biosci2005101499150915769640
  • KrishnaRMayerLDMultidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugsEur J Pharm Sci20001126528311033070
  • ChenTShukoorMIWangRSmart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imagingACS Nano2011578667867321888350
  • LammersTAimeSHenninkWEStormGKiesslingFTheranostic nanomedicineAcc Chem Res2011441029103821545096
  • Caldorera-MooreMELiechtyWBPeppasNAResponsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriersAcc Chem Res2011441061107021932809
  • KievitFMZhangMCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriersAdv Mater201123H21724721842473
  • ShapiraALivneyYDBroxtermanHJAssarafYGNanomedicine for targeted cancer therapy: towards the overcoming of drug resistanceDrug Resist Updat20111415016321330184
  • IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov Today20061181281816935749
  • WangMThanouMTargeting nanoparticles to cancerPharmacol Res201062909920380880
  • RuoslahtiEBhatiaSNSailorMJTargeting of drugs and nanoparticles to tumorsJ Cell Biol201018875976820231381
  • LeiTSrinivasanSTangYComparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanismsNanomedicine2011732433221094277
  • FerrisDPLuJGothardCSynthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cellsSmall201171816182621595023
  • BenezraMPenate-MedinaOZanzonicoPBMultimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanomaJ Clin Invest20111212768278021670497
  • RosenholmJMMeinanderAPeuhuETargeting of porous hybrid silica nanoparticles to cancer cellsACS Nano2009319720619206267
  • LeeSYunHSKimSHThe comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosisBiomaterials2011329434944321889200
  • WangTZhangLSuZWangCLiaoYFuQMultifunctional hollow mesoporous silica nanocages for cancer cell detection and the combined chemotherapy and photodynamic therapyACS Appl Mater Interfaces201132479248621604817
  • YeYLiuJXuJSunLChenMLanMNano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell lineToxicol In Vitro20102475175820060462
  • LuXQianJZhouHIn vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cellsInt J Nanomedicine201161889190121931484
  • CorbalanJJMedinaCJacobyAMalinskiTRadomskiMWAmorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effectsInt J Nanomedicine201162821283522131828
  • GiriSTrewynBGLinVSMesoporous silica nanomaterial-based biotechnological and biomedical delivery systemsNanomedicine (Lond)200729911117716196
  • LaiSKHidaKManSTPrivileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non- degradative pathwayBiomaterials2007282876288417363053
  • LunovOSyrovetsTLoosCDifferential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell lineACS Nano201151657166921344890
  • YanagisawaRTakanoHInoueKIKoikeESadakaneKIchinoseTSize effects of polystyrene nanoparticles on atopic dermatitis-like skin lesions in NC/NGA miceInt J Immunopathol Pharmacol20102313114120378001
  • SmithPGiroudMWigginsECellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilizationInt J Nanomedicine201272045205522619541
  • GianottiEBertolinoCABenziCPhotoactive hybrid nanomaterials: indocyanine immobilized in mesoporous MCM-41 for “in-cell” bioimagingACS Appl Mater Interfaces2009167868720355990
  • CastinoRPeracchioCSaliniAChemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loopJ Cell Mol Med2009131096110918657225
  • StraubingerRMLopezNGDebsRJHongKPapahadjopoulosDLiposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomesCancer Res198848523752453409248
  • HamelersIHStaffhorstRWVoortmanJHigh cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosisClin Cancer Res2009151259126819228729
  • WiechenKDiatchenkoLAgoulnikACaveolin-1 is downregulated in human ovarian carcinoma and acts as a candidate tumor suppressor geneAm J Pathol20011591635164311696424
  • BurghardtRCBarhoumiRLewisEHPatulin-induced cellular toxicity: a vital fluorescence studyToxicol Appl Pharmacol19921122352441539161
  • CastinoRFiorentinoICagninMGioviaAIsidoroCChelation of lisosomal iron protects dopaminergic SH-SY5Y neuroblastoma cells from hydrogen peroxide toxicity by precluding autophagy and Akt dephosphorylationToxicol Sci201112352354121742779
  • EkkapongpisitMGioviaANicotraGOzzanoMCaputoGIsidoroCLabeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticlesInt J Nanomedicine201271829184022605932
  • LakadamyaliMRustMJZhuangXLigands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomesCell2006124997100916530046
  • PichlerHRiezmanHWhere sterols are required for endocytosisBiochim Biophys Acta20041666516115519308
  • KilsdonkEPYanceyPGStoudtGWCellular cholesterol efflux mediated by cyclodextrinsJ Biol Chem199527017250172567615524
  • DombuCYKroubiMZiboucheRMatranRBetbederDCharacterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cellsNanotechnology20102135510220689164
  • ParkMVNeighAMVermeulenJPThe effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticlesBiomaterials2011329810981721944826
  • LuJLiongMZinkJITamanoiFMesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugsSmall200731341134617566138
  • XiaTKovochichMLiongMZinkJINelAECationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathwaysACS Nano20082859619206551
  • GessnerALieskeAPaulkeBRMüllerRHFunctional groups on polystyrene model nanoparticles: influence on protein adsorptionJ Biomed Mater Res A20036531932612746878
  • NelAEMädlerLVelegolDUnderstanding biophysicochemical interactions at the nano-bio interfaceNat Mater2009854355719525947
  • DausendJMusyanovychADassMUptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cellsMacromol Biosci200881135114318698581
  • RejmanJOberleVZuhornISHoekstraDSize-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosisBiochem J200437715916914505488
  • JohnstonHJSemmler-BehnkeMBrownDMKreylingWTranLStoneVEvaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitroToxicol Appl Pharmacol2010242667819799923
  • dos SantosTVarelaJLynchISalvatiADawsonKAEffects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell linesPLoS One20116e2443821949717
  • MerhiMDombuCYBrientAStudy of serum interaction with a cationic nanoparticle: Implications for in vitro endocytosis, cytotoxicity and genotoxicityInt J Pharm2012423374421801821
  • BaierGCostaCZellerABSA adsorption on differently charged polystyrene nanoparticles using isothermal titration calorimetry and the influence on cellular uptakeMacromol Biosci20111162863821384550
  • FazlollahiFAngelowSYacobiNRPolystyrene nanoparticle trafficking across MDCK-IINanomedicine2011758859421310266